Clinical trial
Evaluation of Clinical Outcomes of Transseptal Transcatheter Mitral Valve-in-Valve Replacement for Degenerated Bioprostheses - The China Mviv Registry
NCT05925335 is registered in ClinicalTrials.gov with Xiamen Cardiovascular Hospital, Xiamen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Clinical Outcomes of Transseptal Transcatheter Mitral Valve-in-Valve Replacement for Degenerated Bioprostheses - The China Mviv Registry
- Lead sponsor
- Xiamen Cardiovascular Hospital, Xiamen University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 11, 2023
- Completion date
- June 11, 2025
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bioprosthesis failure, heart failure, mitral regurgitation, mitral stenosis, mitral stenosis with insufficiency